Public scrutiny of LASIK reached a new level in April 2008 at the US Food and Drug Administration's (FDA) Ophthalmic Devices Advisory Panel hearing on post-LASIK quality-of-life issues. The discussion was a response to more than 140 letters of complaint addressed to the FDA regarding LASIK complications.1
It is without doubt that a variety of causes contribute to patients' dissatisfaction with LASIK; however, I am of the firm opinion that a high proportion of these patients are genuinely dissatisfied with their refractive outcomes, including patients with an excess amount of remaining corneal astigmatism. Many of these problematic cases can be predicted prior to refractive surgery by determining the patient's ocular residual astigmatism (ORA). This occurs when a larger-than-usual discrepancy between the corneal and refractive astigmatism measurements is evident. This relatively common predicament is avoidable if the surgeon employs vector planning and uses a combination of topography and wavefront refractive data for treatment. Vector planning reduces a greater amount of corneal astigmatism versus treatments using refractive parameters only.2
The ORA is determined by calculating the vectorial difference between refractive cylinder, as measured by wavefront or manifest refraction, and corneal astigmatism, as measured by topography or keratometry measurements for corneal astigmatism.3,4 The ORA vector is transferred to the origin (x=0, y=0) and halved to simulate how it would exist within the eye (Figure 1). This difference, measured in diopters and degrees and calculated using basic trigonometric principles, has a proportional relationship with astigmatism. As the astigmatic difference between refractive and corneal astigmatism increases, the magnitude of the ORA also increases. Therefore, the amount of residual postoperative astigmatism is also greater. This would all be left on the cornea using conventional refractive techniques.
It is my belief that if ORA assessment was a routine part of the preoperative exam, then the unfortunate occurence of residual refractive error after LASIK—as well as the FDA panel hearing and its subsequent prospective evaluation of LASIK satisfaction—would likely have been avoidable where adverse refractive outcomes occurred. The prospective quality-of-life study is scheduled to begin in 2009 and will be jointly conducted by the US FDA, the National Eye Institute, the American Society of Cataract and Refractive Surgery (ASCRS), and the American Academy of Ophthalmology (AAO). Participating surgeons will study the change in patients' quality of life after LASIK and the factors associated with postoperative satisfaction or dissatisfaction.
WHAT IS VECTOR PLANNING?
Although wavefront-customized treatments offer many benefits to our patients, wavefront refraction alone does not entirely treat astigmatism. In fact, it may create an excessive amount of residual corneal astigmatism and increase the irregularity of the cornea when used alone.3,5-8 Alternatively, topography-guided treatments, which are typically used to treat irregular corneas after previous corneal surgery, may induce higher-order aberrations.9
I have published two studies in the past 2 years3,4 discussing the combination of topography and refractive data for a vectorial approach to PRK and LASIK. I believe that using vector planning is the final piece missing from the refractive surgery puzzle. It demonstrates a fundamental and unique ability to combine topographic with refractive astigmatism parameters in an effective, optimized manner. The main goal of vector planning is to aim closer to corneal sphericity, particularly in patients who have an expected unfavorable astigmatism orientation, including cases of oblique and against-the-rule astigmatism.
Herein, I will describe my latest results with treatments that combine topography and wavefront refractive parameters. My colleagues and I recently reported that patients achieve superior visual results under mesopic conditions (ie, low light situations) and have a greater reduction in horizontal coma and corneal astigmatism when wavefront is combined with topography values.10
To our knowledge, this is the first study to combine topographic astigmatism and wavefront aberrometry cylinder into one treatment paradigm. Between October 2005 and March 2006, we evaluated wavefront-guided LASIK outcomes in 21 eyes with myopic astigmatism—10 with wavefront and topography combined and 11 with wavefront alone in the surgical plan. The treatment profile for the combined group was modified according to my planning module, the Alpins Statistical System for Ophthalmic Refractive surgery Techniques (ASSORT). This module combines topographic data with the measured wavefront aberrometry and adjusts the CustomVue treatment profile (Advanced Medical Optics, Inc., Santa Ana, California). The measurements of higher-order aberrations were not modified.
We chose to vary the wavefront aberrometry treatment of patients in the combined group as follows: Instead of leaving 100% of the ORA corrected on the cornea, we left only 60%. Additionally, we left 40% of ORA in the wavefront refraction (Figure 2). This 40/60 emphasis on the ORA was chosen because it significantly reduces the corneal astigmatism without compromising the refractive astigmatism outcome.2 If the surgeon wanted, however, he could choose to incorporate any percentage of topography parameters, determining them based on each individual patient, to optimize the treatment and minimize the remaining corneal and refractive astigmatism. Treatment for the wavefront- alone group was chosen based on standard aberrometry measurements from the WaveScan system, leaving 100% of the ORA on the cornea.
SURGICAL TREATMENT, OUTCOMES
Patients remained in a dark room for approximately 15 minutes prior to assessment. A minimum of three aberrometry acquisitions with the WaveScan WaveFront system were achieved for each patient. At the time of surgery, we created a corneal flap with a nasal hinge using a 140-µm head microkeratome (Amadeus; Ziemer Group AG, Port, Switzerland). We left a residual stromal bed of at least 270 µm in each eye and used the Visx Star S4 excimer laser with CustomVue software (Advanced Medical Optics, Inc.) to perform the ablation. We used iris registration and tracking in both groups.
After laser vision correction was complete, we covered all eyes with plastic shields overnight. Patients were also asked to wear the shields during sleep for the following two nights. Follow-up visits were scheduled for day 1 and at 1, 3, and 6 months postoperatively.
Prior to surgery, mean ORA of the combined topography-wavefront group was 1.06 ±0.23 D and 1.00 ±0.16 D in the wavefront-alone group. At 6 months, that figure was 0.82 ±0.42 D and 0.73 ±0.25 D, respectively. Mean preoperative corneal astigmatism (by topography) was 1.50 D in the combined group and 1.07 D in the wavefront-alone group; however, at 6 months, the mean reduction was 44% in the combined group and 39% in the wavefront-alone group. Comparatively, mean preoperative astigmatism (by wavefront refraction) was -1.69 diopters of cylinder and -1.71 diopters of cylinder in the combined and wavefront-alone groups, respectively, and the mean reduction was 55% versus 69% at 6 months. When both wavefront and topography parameters were used, the mean total astigmatic reduction at 6 months was similar in both groups (-1.62 D in the combined group vs -1.58 D in the wavefront-alone group); however, the combined group had a greater mean reduction in total astigmatism when manifest and keratometry measurements were used. Additionally, the horizontal coma decreased by 0.04 µm in the combined group compared with a gain of 0.02 µm in the wavefront-alone group.
We observed that the combined wavefront and vector planning treatments had a greater chance for improvement in BCVA. Although both groups had the same mean preoperative BCVA and similar low- and high-contrast visual acuities under mesopic conditions, the gain in low-contrast visual acuity under mesopic conditions at 6 months was 0.05 more for the combined group (0.11 vs 0.06). When we looked at high-contrast visual acuity under mesopic conditions, the combined group experienced a 0.05 gain, whereas the wavefront-alone group gained only 0.02. Gains were identical under photopic conditions. When lines of BCVA were studied, there was a greater potential for improvement in BCVA for the combined group.
We have been pleased with the treatment outcomes when combining topography with refractive wavefront parameters; however, there are several limitations to the current technology that could be improved. These include a variation in measurements obtained from topographic and wavefront devices, usually resulting in difficulty obtaining the most consistent numbers from each technology. Additionally, wavefront technology displays one overall refraction—this could be extended to multiple refractions relating to the topographic map.
Further advances in technology may increase the efficacy of treatment by allowing higher-order aberrations to reflect any modification present during vector planning. Additionally, the method of vector planning could be repeated over the entire ablation profile by having a shape profile of the cornea that maps directly with the shape profile of the wavefront. Such advances can occur only if laser manufacturers modify their treatment profiles to enable rotation of the treatment axis.
In 2006, the American National Standards Institute adopted my astigmatism vector analysis technique for refractive outcomes11 as a standard to evaluate the safety and effectiveness of laser systems that reshape the cornea when treating astigmatism. I have confidence that it is only a matter of time before this vector planning technique3 will also be adopted as a standard of care.
With this strategy for treatment planning, the downturn in the number of patients currently looking into or undergoing LASIK in Europe as well as the United States may be reversed. Although a small nucleus of patients might remain ambivalent or unsympathetic to the procedure—which could continue to prevent absolute acceptance of laser vision correction—it is my belief that addressing astigmatic treatment, and hence visual outcomes, will again increase the interest in LASIK surgery. The inclusion of vector planning integrates topographic and wavefront data into a systematic treatment paradigm that is a significant advance to achieving the ideal treatment profile.
Noel Alpins, FRANZCO, FRCOphth, FACS, is an Associate Fellow at the University of Melbourne, Victoria, Australia. Dr. Alpins states that he has a financial interest in the ASSORT program used for calculation of the treatment parameters and examination of outcomes. He may be reached at tel: +61 3 9584 6122; fax: +61 3 9585 0995; e-mail: email@example.com.